Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study
-
Published:2024-08
Issue:
Volume:
Page:102185
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Fotia GiuseppeORCID, Saieva Calogero, Lee-Ying RichardORCID, Patrikidou Anna, Nuzzo Pier VitaleORCID, Zanardi Elisa, Rossetti Sabrina, Davidsohn Matthew, Eid MarcORCID, El Zarif TalalORCID, McClure Heather, Spinelli Gian PaoloORCID, Damassi Alessandra, Murianni Veronica, Vauchier Charles, Oliveira Thiago Martins, Malgeri Andrea, Modesti Mikol, Mestre Ricardo Pereira, Valenca Loana, Ravi Praful, Santini Daniele, Pignata Sandro, De Giorgi Ugo, Sweeney ChristopherORCID, Heng Daniel, Procopio Giuseppe, Russo Antonio, Francini EdoardoORCID
Reference29 articles.
1. Estimated Number of New Cases: Age-Specific Tables 2020. GLOBOCAN,2020 2. Cancer statistics;Siegel;CA A Cancer J Clin,2021 3. Prostate Cancer,2021 4. New treatment developments applied to elderly patients with advanced prostate cancer;Mukherji;Cancer Treat Rev,2013 5. Treatment of prostate cancer in unfit senior adult patients;Falci;Cancer Treat Rev,2009
|
|